← Back to Patent Explorer
US3980631A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel analogs of deamino-vasopressin with a modified disulfide bridge and manufacturing process thereof

Assignee: Czech Academy of Sciences
•
Filing: 1974-10-07
•
Granted: 1976-09-14
•
Expires: 1994-10-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Stepwise synthesis in solution and cyclization by means of active esters or another method suitable for peptide bond formation were used to prepare analogues of deamino-vasopressin with the disulphide bridge altered to the thioether group. In sequence position 8 of the peptide chain the analogs differed by the nature of basic amino acid. Typical vasopressin-like activities, mainly antidiuretic, were very high in these analogs; of particular importance will be their haemodynamic activity.

Inventors

  • 👤 Zdenko Prochazka
  • 👤 Tomislav Barth
  • 👤 Joseph Henry Cort
  • 👤 Karel Jost
  • 👤 Frantisek Sorm

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 12:40
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/10; C07K5/1002; C07K5/1005; A; A61; A61P; A61P5/00; C07K7/00; C07K7/04; C07K7/16; A61K; A61K38/00; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/15

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 75 words
An analog of deamino-vasopressin having a modified disulfide bridge and having the formula ##EQU3## wherein X is --S--CH 2 -- and Y is an aliphatic group containing 2, 3 or 5 carbon atoms, in which group the α-carbon atom possesses L- or D-configuration and the terminal ω-carbon atom carries a member selected from the group consisting of amino and guanidino; and the hydroxy group on the tyrosine residue is optionally protected by a tert-butyl group.
Claim 2
Dependent Claim 75 words
An analog of deamino-vasopressin having a modified disulfide bridge and having the formula ##EQU3## wherein X is --S--CH 2 -- and Y is an aliphatic group containing 2, 3 or 5 carbon atoms, in which group the α-carbon atom possesses L- or D-configuration and the terminal ω-carbon atom carries a member selected from the group consisting of amino and guanidino; and the hydroxy group on the tyrosine residue is optionally protected by a tert-butyl group.
Claim 3
Dependent Claim 13 words
An analog according to claim 1 designated as a lactam of O-tert-butyltyrosyl-phenylalanyl-glutaminyl-asparaginyl-S-β-carboxyethylhomocysteinyl-prolyl-ω-benzyloxycarbonyl-ornithyl-glycine amide.
Claim 4
Dependent Claim 13 words
An analog according to claim 1 designated as a lactam of tyrosyl-phenylalanyl-glutaminyl-asparaginyl-S-β-carboxyethylhomocysteinyl-prolyl-ornithyl-glycine amide.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-09-14 1980-03-15 1980-09-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-09-14 1984-03-15 1984-09-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-09-14 1988-03-15 1988-09-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag